Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapse - PubMed (original) (raw)
. 2013 Apr 15;6(5):917-25.
Print 2013.
Affiliations
- PMID: 23638224
- PMCID: PMC3638103
Intestinal protein expression profile identifies inflammatory bowel disease and predicts relapse
Jun Shen et al. Int J Clin Exp Pathol. 2013.
Abstract
To date, most studies have applied individual factors as indicators of disease classification and prognosis. The aim of this study is to determine whether clustering analysis of protein expression profiles in intestinal epithelia improves classification and prognosis in patients with inflammatory bowel disease (IBD). One hundred and twenty Crohn's disease (CD) patients, 117 ulcerative colitis (UC) patients and 120 cases of nonspecific colitis provided intestinal biopsy samples for tissue microarray (TMA). Both unsupervised and supervised analyses were used for evaluation of clustering and association with relapse. There was a significant concordance between cluster groups based on immunostaining data of TMA and clinical classification in distinguishing IBD from nonspecific colitis (kappa= 0.498, p<0.001). CD27, CD70, CD40, TRAF3, TRAF4 and TRAF2 presented similar immunostaining features, which were different from clusters of CD154, CD80 and TRAF5. Moreover, higher expression of TRAF2 was a predictor of relapse in patients with UC (p=0.006).Thus, protein expression profiles can distinguish IBD and nonspecific colitis, and combination analysis protein expression profiles show that TRAF2 can predict relapse of UC.
Keywords: Crohn’s disease; classification; relapse; ulcerative colitis.
Figures
Figure 1
Protein expression profiles studied by immunohistochemistry on tissue microarrays. A. HE stain of paraffin blocks with 0.6 mm tissue cores. B. Examples of immunohistochemistry staining for 10 proteins. Magnification ×200 or ×400. CD, Crohn’s disease; UC, ulcerative colitis; NC, nonspecific.
Figure 2
Hierarchical clustering analysis of protein expression profiles in non-specific colitis (A), Crohn’s disease (B) and ulcerative colitis (C) as measured by tissue microarray. Graphical representation of hierarchical clustering results based on expression profiles of proteins. Rows, samples; columns, proteins. Protein expression scores are depicted according to a color scale: red, positive staining; green, negative staining; black, zero; gray, missing data. Dendrograms of samples (to the left of matrix) and proteins (above matrix) represent overall similarities in expression profiles. In the dendrogram, the length of branch between two elements reflects their degree of relatedness. A trend towards cluster of nonspecific colitis (purple dendrograms to the left of matrix, zoomed in A) is shown to classify patients with inflammatory bowel disease and nonspecific colitis. Two major protein clusters are identified (above matrix).
Similar articles
- Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.
Shen J, Qiao YQ, Ran ZH, Wang TR. Shen J, et al. Int J Med Sci. 2013;10(2):156-63. doi: 10.7150/ijms.5457. Epub 2013 Jan 3. Int J Med Sci. 2013. PMID: 23329887 Free PMC article. - Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
Walkiewicz D, Werlin SL, Fish D, Scanlon M, Hanaway P, Kugathasan S. Walkiewicz D, et al. Inflamm Bowel Dis. 2008 May;14(5):669-73. doi: 10.1002/ibd.20376. Inflamm Bowel Dis. 2008. PMID: 18240279 - Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.
Nterma P, Panopoulou E, Papadaki-Petrou E, Assimakopoulou M. Nterma P, et al. Pathol Oncol Res. 2020 Jan;26(1):567-574. doi: 10.1007/s12253-018-00575-z. Epub 2019 Jan 2. Pathol Oncol Res. 2020. PMID: 30604274 - Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America; Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, Glickman JN, Gold BD, Griffiths AM, Jevon GP, Higuchi LM, Hyams JS, Kirschner BS, Kugathasan S, Baldassano RN, Russo PA. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition, et al. J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460505 - Visceral adiposity and inflammatory bowel disease.
Rowan CR, McManus J, Boland K, O'Toole A. Rowan CR, et al. Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
Cited by
- Tumor Necrosis Factor Receptor-Associated Factor Regulation of Nuclear Factor κB and Mitogen-Activated Protein Kinase Pathways.
Shi JH, Sun SC. Shi JH, et al. Front Immunol. 2018 Aug 9;9:1849. doi: 10.3389/fimmu.2018.01849. eCollection 2018. Front Immunol. 2018. PMID: 30140268 Free PMC article. Review. - TRAF3: a novel tumor suppressor gene in macrophages.
Lalani AI, Luo C, Han Y, Xie P. Lalani AI, et al. Macrophage (Houst). 2015 Sep 30;2:e1009. doi: 10.14800/macrophage.1009. Macrophage (Houst). 2015. PMID: 26661944 Free PMC article. - Targeting signaling factors for degradation, an emerging mechanism for TRAF functions.
Yang XD, Sun SC. Yang XD, et al. Immunol Rev. 2015 Jul;266(1):56-71. doi: 10.1111/imr.12311. Immunol Rev. 2015. PMID: 26085207 Free PMC article. Review. - TRAF molecules in inflammation and inflammatory diseases.
Lalani AI, Zhu S, Gokhale S, Jin J, Xie P. Lalani AI, et al. Curr Pharmacol Rep. 2018 Feb;4(1):64-90. doi: 10.1007/s40495-017-0117-y. Epub 2017 Dec 20. Curr Pharmacol Rep. 2018. PMID: 29527458 Free PMC article. - An integrative network-based approach to identify novel disease genes and pathways: a case study in the context of inflammatory bowel disease.
Eguchi R, Karim MB, Hu P, Sato T, Ono N, Kanaya S, Altaf-Ul-Amin M. Eguchi R, et al. BMC Bioinformatics. 2018 Jul 13;19(1):264. doi: 10.1186/s12859-018-2251-x. BMC Bioinformatics. 2018. PMID: 30005591 Free PMC article.
References
- Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implications. Am J Gastroenterol. 2000;95:878–896. - PubMed
- Schulze HA, Häsler R, Mah N, Lu T, Nikolaus S, Costello CM, Schreiber S. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD. Genes Immun. 2008;9:240–248. - PubMed
- Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B Ibsen Study Group. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study) Scand J Gastroenterol. 2006;41:1037–1043. - PubMed
- Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C, Ho GT, Satsangi J, Bloom S IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571–607. - PubMed
- Casellas F, Barreiro de Acosta M, Iglesias M, Robles V, Nos P, Aguas M, Riestra S, de Francisco R, Papo M, Borruel N. Mucosal healing restores normal health and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2012;24:762–769. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials